Skip to content

A Prospective Randomized Comparison of Three Methods for Fixation of Hammertoes

A Prospective Randomized Comparison of Three Methods for Fixation of Hammertoes

Status
Withdrawn
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01927952
Enrollment
0
Registered
2013-08-23
Start date
2013-09-30
Completion date
2016-12-31
Last updated
2013-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acquired Deformities of Toe

Keywords

hammertoe

Brief summary

The purpose of this research project is to compare three different methods for fixation of hammertoe deformities: (1) Kirschner wire; (2) Integra IPP-ON PIP Fusion System; and (3) Stryker Smart-Toe implant.

Detailed description

This is a prospective, randomized study and will assist us in ascertaining which of the three tested interventions has the most beneficial outcome.

Interventions

Surgical fixation utiliziing Kirschner wire

PROCEDUREIntegra IPP-On PIP Fusion System

surgical fixation utilizing the Integra IPP-On PIP Fusion System

PROCEDUREStryker Smart-Toe Implant

surgical fixation utilizing the Stryker Smart-Toe Implant

Sponsors

Susan Hassenbein
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult subjects (greater than or equal to 18 years of age) diagnosed with hammertoe deformity, acquired (ICD9 734.5) requiring surgical fixation * Subject has given voluntary, written informed consent to participate in this clinical investigation. * Subject, in the opinion of the clinical investigator, is able to understand the clinical investigation and is willing to perform all study procedures and follow-up visits * Subject must be comfortable with speaking, reading, and understanding questions and providing responses in an available translated language.

Exclusion criteria

* Subjects less than 18 years of age * Subjects with peripheral or central neurologic disease causing neurologic symptoms, including pain, dysthesia, or numbness of the operative leg * Subjects diagnosed with complicated diabetes mellitus with noted neuropathy, diagnosed by the 10-g monofilament test * Inability to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Complicationschange from baseline to 12 weeksWill look at number of participants with complications/adverse events including: floating toe, recurrence of hammertoe, soft tissue infection, medial/lateral mal-alignment at PIP joint, plantar flexion/hyperextension mal-alignment at DIP joint, rotation of toe and need for revision surgery.

Secondary

MeasureTime frameDescription
Functional Outcomechange from baseline to 12 weeksWill look at functional outcomes of patients as reported in the Foot and Ankle Ability Measure (FAAM) questionnaire administered to patients to assess their function pre- and post-surgery.
Patient Satisfactionchange from baseline to 12 weeksWill look at overall patient satisfaction with surgical care via a questionnaire administered to patients.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026